4//SEC Filing
Ackermann Michael 4
Accession 0001209191-21-050631
CIK 0001819790other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:55 PM ET
Size
6.3 KB
Accession
0001209191-21-050631
Insider Transaction Report
Form 4
Ackermann Michael
Director10% Owner
Transactions
- Sale
Common Stock
2021-08-09$25.00/sh−700$17,500→ 1,227,969 total - Sale
Common Stock
2021-08-06$25.00/sh−3,129$78,225→ 1,228,669 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001791249
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:55 PM ET
- Size
- 6.3 KB